1. Home
  2. ERII vs RGNX Comparison

ERII vs RGNX Comparison

Compare ERII & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$8.11

Market Cap

595.9M

Sector

Technology

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$6.97

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
RGNX
Founded
1992
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
595.9M
528.6M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
ERII
RGNX
Price
$8.11
$6.97
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$17.07
$28.75
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
18.08
EPS
N/A
N/A
Revenue
$134,987,000.00
$10,393,000.00
Revenue This Year
N/A
$51.21
Revenue Next Year
$20.55
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$8.14
$5.46
52 Week High
$18.31
$16.19

Technical Indicators

Market Signals
Indicator
ERII
RGNX
Relative Strength Index (RSI) 33.47 42.45
Support Level N/A $5.46
Resistance Level $11.58 $10.13
Average True Range (ATR) 0.42 0.66
MACD -0.02 -0.06
Stochastic Oscillator 1.61 25.57

Price Performance

Historical Comparison
ERII
RGNX

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: